Helicobacter pylori. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Intervention group: Two weeks of helicobacter pylori triple therapy, including daily intake of pantoprazole 80 mg , amoxicillin 2 g, bismuth 8 mg and clarithromycin 1 g + cranberry jui
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18 to 65 years old Helicobacter pylori infection Gastrointestinal complaints Body mass index 18.5 to 35 kg / m2
Exclusion criteria
Exclusion criteria: Having a history of drug therapy to eradicate Helicobacter pylori infection Stomach surgery History of peptic ulcer and gastrointestinal malignancies Having any disease that causes inflammation and increased levels of inflammatory markers, such as diabetes, cardiovascular disease, respiratory infections such as asthma and ... Getting immunodeficiency diseases Developing chronic diseases requiring drug treatment Taking medications other than prescription drugs Receiving antibiotics or proton pump inhibitors or H2 blockers over the past 2 months Taking omega supplementation At least 3 months before the start of the study Use of any diet supplements During the study 3 months before the start of the study Changes in the diet during the study period Consumption of less than 80% of the supplements delivered to the patient during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Negative cases of Helicobacter pylori infection. Timepoint: Three weeks after the end of treatment. Method of measurement: Checking of H.Pylori stool antigen.;Scale of gastrointestinal complaints questionnaire from Helicobacter pylori infection. Timepoint: Before and at the end of the study. Method of measurement: Questionnaire.;Serum levels of Il-17, TGFß1 and INF-?. Timepoint: Before and at the end of the study. Method of measurement: ELISA method.;Serum levels of TAC and MDA. Timepoint: Before and after study. Method of measurement: ELISA method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Maghsoumi-Nourozabad
Ahvaz University of Medical Sciences
Outcome results
None listed